
Brazil’s antitrust watchdog, CADE, has announced an extension for the deadline granted to State-run oil giant Petrobras to sell its oil refining business. The sale of Petrobras’ refineries would help it fulfill obligations assumed by the company in an agreement to stimulate competition in the local oil refining market, the agency said.
The new schedule for the sales was not disclosed by CADE in order to avoid affecting ongoing negotiations regarding the assets to be divested, according to a statement.
CADE signed two historic agreements with Petrobras in 2019. The first, a Cease and Desist Agreement (a type of leniency programme) resolved the watchdog’s investigation into claims that Petrobras abused its dominant position in the oil refining market.
Under the agreement, Petrobras agreed to sell eight of its refineries and associated transport assets. The measure aims to increase competition in the national refining market by encouraging the arrival of new entrants and, thus, attracting investment in the sector.
CADE’s approach to embattled oil giant Petrobras is yet another example of the regulator’s efforts to consolidate competition in Brazil’s oil markets almost 25 years after the changes to the country’s Federal constitution that ended the oil company’s official monopoly over the South American country’s energy sector.
This is the second extension granted to Petrobras to complete the sales. The first deadline, set for 2021, was extended in April of that year in consideration of the global turmoil caused by the COVID-19 pandemic and the subsequent disruptions to global economies that slowed down the sales processes.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas